ENT Devices Market Segmentation, Application, Trends, Opportunity & Forecast 2024 To 2030
ENT
Devices Industry Overview
The global ENT devices market size was estimated at USD 25.93
billion in 2023 and is expected to grow at a compound annual growth rate (CAGR)
of 5.54% from 2024 to 2030. This growth can be attributed to several factors,
such as high prevalence of ENT-related disorders, an increase in the usage of
minimally invasive ENT procedures, and rising geriatric population.
Technological advancements also play a crucial role in driving the market
growth.
The demand for advanced ENT devices, like robot-assisted
endoscopes, is more in developed countries such as the U.S. while it is less in
developing countries due to their high cost. The ENT devices market penetration
is anticipated to grow significantly due to increasing healthcare spending by
other governments and a rise in per capita income. Sales are expected to
increase rapidly in developing economies due to high occurrences of ENT
diseases such as hearing loss and sinusitis. Additionally, there is an increase
in efforts to provide better access to healthcare facilities in these regions.
Gather
more insights about the market drivers, restrains and growth of the ENT Devices Market
Hearing loss or impairment is a common condition among patients,
particularly in industrialized countries. The World Health Organization
reported, more than 430 million people worldwide, approximately 5% of the
world's population, have a disabling hearing loss. This number is projected to
rise to over 700 million, or one in every ten people, by 2050. The main reasons
for this increase are growing life expectancy and noise pollution, leading to
more age-related hearing loss cases. In low-income countries, infections such
as middle ear infections, measles, or meningitis are the common causes of
hearing loss. Moreover, vascular disorders, noise exposure, chronic
inflammation, genetic susceptibility, physiological aging of the ear
contributing to hearing impairment.
Rising technological advancements such as the adoption of AI and
ML and innovations in auditory products are propelling industry growth. For
instance, in September 2023, ELEHEAR Inc., an AI-powered hearing aids and audio
solutions provider, introduced ELEHEAR Alpha Pro and ELEHEAR Alpha hearing aid
devices. It is incorporated with AI noise reduction and extraction, which
predicts daily users and their actions to minimize the effect of noise in
typical audio environments such as public transit, offices, restaurants, homes,
and busy streets. In March 2023, Oticon Medical A/S introduced new features in
the processing chip Polaris R, which uses an onboard Deep Neural Network (DNN)
for an entirely new method of sound processing. The updated processing chip features
include sudden sound stabilizer and Wind & Handling Stabilizer.
Browse
through Grand View Research's Medical Devices Industry Research Reports.
• The global intrauterine
devices market size was estimated at USD 6.25 billion in 2023 and is projected
to grow at a CAGR of 3.66% from 2024 to 2030.
• The global dual
chamber prefilled syringes market size was valued at USD 167.3 million
in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030.
Key ENT
Devices Company Insights
Some of the key market players include, Cochlear Ltd., Demant A/S,
Stryker, and KARL STORZ.
Cochlear Ltd. (Cochlear) engages in developing and commercializing
cochlear implants, bone conduction implants, & acoustic implants to treat
hearing-impaired individuals. Cochlear Ltd. is a global company with major
manufacturing facilities in Sweden and Australia.It has a global presence in
more than 180 countries.
Demant A/S (Demant) is a global company that develops,
manufactures, and commercializes hearing implants, traditional hearing
instruments, personal communication devices, & diagnostic instruments. The
group operates in over 30 countries and sells its products in over 130
countries.
Nemera., Nico Corporation, and Rion Co., Ltd. are the emerging
market participants.
Nemera, founded in 2003, is a medical equipment manufacturer
specializing in a diverse product portfolio, including Ear, Nose, Throat, Nasal
spray pumps, drug delivery devices, ophthalmic, and others. In 2021, Nemera
established an operational base in Brazil and expanded its product and service
offerings throughout Latin America.
NICO Corporation is a medical technology company that specializes
in developing minimally invasive surgical solutions, particularly in the fields
of neurosurgery and otolaryngology (ear, nose, and throat or ENT)
Key ENT
Devices Companies:
The following are the leading companies in the ENT devices market.
These companies collectively hold the largest market share and dictate industry
trends. Financials, strategy maps & products of these ENT devices companies
are analyzed to map the supply network.
·
Ambu A/S
·
Cochlear Ltd.
·
Demant A/S
·
GN Store Nord A/S
·
Karl Storz SE & Co.
·
Olympus Corporation
·
Pentax of America, Inc.
·
Richard Wolf GmbH
·
Rion Co., Ltd.
·
Smith & Nephew plc
·
Sonova
·
Starkey Laboratories, Inc.
·
Stryker
·
Nico Corporation
·
Nemera
Recent
Developments
In April 2023, Unitron, a brand of Sonova launched Vivante, a
platform aimed to enhance listener’s experience through personalized hearing
control. This platform offers improved sound performance and new designs to
enhance the hearing experience, integrating
experience innovations and the remote plus app to offer a customized
hearing experience.
In February 2023, Cochlear Ltd. announced a partnership with
Amazon.com, Inc. to expand audio streaming for hearing aids for people with
Cochlear's hearing implants to provide comfortable entertainment.
In November 2022, Cochlear Ltd. announced the expansion of its
manufacturing facility plant in Kuala Lumpur, Malaysia. The expansion involved
an asset of more than USD 6.28 million (RM 30 million) to help the growing
demand for acoustic and cochlear hearing implants
Order a free sample PDF of the
ENT Devices Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment